Alpha Diagnostic International, Inc. Anti-Human Neuroligin 3 (NLGN3) Control/blocking peptide NLGN31-P

Anti-Human Neuroligin 3 (NLGN3) Control/blocking peptide General Information Neuroligins are Type I membrane proteins enriched in synaptic plasma membranes and clustered in synaptic clefts and postsynaptic densities. They have been characterized as neuronal cell surface proteins and are thought to be involved in cell-cell-interact SugApplications Control or blocking peptides are recommended for ELISA plate coating for direct ELISA testing of antibodies or competitive ELISA, and antibody blocking or neutralization. SpeciesReactivity Human Form Antigen/blocking Peptide Antigen 17- aa peptide of Human NLGN3 (Protein accession # Q9NZ94; ref. 1); designated as NLGN31-P control/blocking peptide conjugated to KLH; epitope location ~ C-terminus, extracellular SpCrossreactivity Human NLGN31-P peptide sequence is 93.7% homologous to both mouse and rat NLGN3 protein sequence. Antibody cross-reactivity in various species is not known. For research use only, not for diagnostic or therapeutic use.